Skip to content

Clinical trials

Leiomyosarcoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Country / region: Belgium Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20051
20071
20081
20111
20121
20151
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC9
Eli Lilly and Company2
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
PharmaMar1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma15
Sarcoma12
Histiocytoma, Malignant Fibrous10
Liposarcoma10
Sarcoma, Synovial10
Fibrosarcoma9
Hemangiosarcoma9
Neurofibrosarcoma8
Rhabdomyosarcoma8
Sarcoma, Alveolar Soft Part4

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.